978 resultados para Stuart, Elisabeth, 1596-1662.
Resumo:
[in Musik gesetzt von] J[acob] Bachmann
Resumo:
Das Schnidejoch ist ein Gebirgspass 2700 Meter hoch in den Berner Alpen, seit tausenden Jahren von Eis bedeckt. Mittlerweile ist fast alles Eis infolge der globalen Klimaerwärmung geschmolzen. SWR2 Kontext-Radiosendung von Elisabeth Brückner.
Resumo:
Der Ötzi ist kein Einzelfall. Immer mehr Hinterlassenschaften der Vorzeit kommen ans Tageslicht, seit die globale Erwärmung nach und nach die alpinen Gletscher zum Schmelzen bringt. Insbesondere am Schnidejoch im Berner Oberland sind Archäologen fündig geworden: Das Eis, das hier jahrtausendelang den Bergsattel bedeckte, ist mittlerweile bis auf einen kleinen Eisfleck geschmolzen und hat rund 900 Artefakte freigegeben. Darunter eine 6.800 Jahre alte Schüssel aus Ulmenholz, eine komplette Jägerausrüstung, römische Schuhnägel aus dem Mittelalter. Und das große Schmelzen geht weiter ...
Resumo:
Boberach: Die vom Verein errichtete Stiftung soll "durch geistige und materielle Mittel das Familienwohl" fördern, die "Geistes- und Herzensbildung besonders des weiblichen Geschlechts" heben und die "unerschütterliche Anhänglichkeit an das Königshaus" befestigen
Resumo:
BACKGROUND Imetelstat, a 13-mer oligonucleotide that is covalently modified with lipid extensions, competitively inhibits telomerase enzymatic activity. It has been shown to inhibit megakaryocytic proliferation in vitro in cells obtained from patients with essential thrombocythemia. In this phase 2 study, we investigated whether imetelstat could elicit hematologic and molecular responses in patients with essential thrombocythemia who had not had a response to or who had had unacceptable side effects from prior therapies. METHODS A total of 18 patients in two sequential cohorts received an initial dose of 7.5 or 9.4 mg of imetelstat per kilogram of body weight intravenously once a week until attainment of a platelet count of approximately 250,000 to 300,000 per cubic millimeter. The primary end point was the best hematologic response. RESULTS Imetelstat induced hematologic responses in all 18 patients, and 16 patients (89%) had a complete hematologic response. At the time of the primary analysis, 10 patients were still receiving treatment, with a median follow-up of 17 months (range, 7 to 32 [ongoing]). Molecular responses were seen in 7 of 8 patients who were positive for the JAK2 V617F mutation (88%; 95% confidence interval, 47 to 100). CALR and MPL mutant allele burdens were also reduced by 15 to 66%. The most common adverse events during treatment were mild to moderate in severity; neutropenia of grade 3 or higher occurred in 4 of the 18 patients (22%) and anemia, headache, and syncope of grade 3 or higher each occurred in 2 patients (11%). All the patients had at least one abnormal liver-function value; all persistent elevations were grade 1 or 2 in severity. CONCLUSIONS Rapid and durable hematologic and molecular responses were observed in patients with essential thrombocythemia who received imetelstat. (Funded by Geron; ClinicalTrials.gov number, NCT01243073.).
Resumo:
Scan von Monochrom-Mikroform
Resumo:
Josef Róna
Resumo:
Josef Róna